Member News

Song and Luján share TWAS prize; Regev to share inaugural James Prize

ASBMB Today Staff
By ASBMB Today Staff
Feb. 15, 2021

Song and Luján share TWAS prize

Erwei Song
Hugo Luján

The World Academy of Sciences, an organization dedicated to promoting scientific research and scientists in the developing world, has announced its 2021 awards, which recognize outstanding achievements and contributions to science by scientists in the Global South. Two ASBMB members, Erwei Song and Hugo Luján, share the award in medical sciences.

Erwei Song, president of Sun Yat-Sen University Medical School in Guangzhou, China, was recognized for his studies of tumor plasticity. Song, a physician–scientist specializing in oncology, found that tumor plasticity can be regulated by pluripotency-related microRNAs and studies the effects of long noncoding RNAs on cancer metastasis and chemoresistance. He also is interested in how tumor cells and tumor-associated macrophages interact; his lab recently reported that extracellular vesicles containing long noncoding RNAs that pass from macrophages to cancer cells can regulate the tumor cells’ biology.

Song trained as a surgeon at Sun Yat-Sen University. He pursued postgraduate medical training at the University of Duisburg-Essen in Germany and postdoctoral research at Harvard Medical School. He became a member of the Chinese Academy of Sciences in 2019.

Hugo Luján, a senior researcher in the faculty of medicine at Argentina’s CONICET, or Universidad Catolica de Córdoba, studies the protozoan intestinal parasite Giardia lamblia. Luján discovered that the parasite uses RNA regulation to change its surface antigens, presenting a shifting coat that confounds the immune system. His lab found a way to weaken the protozoa for use as a vaccine by knocking out its microRNA processing machinery, which forces the parasite to express all of its antigens at once and gives the immune system a chance to recognize all of them. His lab is also studying whether variable surface proteins from giardia might be used for oral delivery of other drugs and vaccines, due to their toughness.

Luján received his doctorate at the Universidad Nacional de Córdoba and conducted postdoctoral research at the National Institutes of Health from 1992 to 1997. He returned to Argentina and was for 10 years a Howard Hughes Institute International research scholar. He has received numerous awards, including a Guggenheim Foundation scholarship, a research award from Argentina’s Konex Foundation and the Georg–Foster prize from Germany’s Alexander von Humboldt Foundation.  

Regev to share inaugural James Prize

Aviv Regev

Aviv Regev, executive vice president of Genentech Research and Early Development, will share the National Academy of Sciences’ James Prize in Science and Technology Integration with Harvard Medical School’s Allon Klein. This is the first year the James Prize is being awarded; it recognizes researchers for contributions that adapt concepts and techniques from outside their own fields, integrating and applying multiple disciplines to solve important problems in science.

The pair is honored for their separate contributions to massively parallel single-cell genomics. Regev, a Howard Hughes Medical Institute investigator until last summer and faculty member at the Broad Institute and Massachusetts Institute of Technology (on leave), developed experimental and analytical tools that drew from biology, computer science and engineering, to pioneer single-cell sequencing. Her research group also showed how to apply these techniques to discover cell types, understand environmental responses and develop cellular atlases that shed light on mechanisms of disease. Meanwhile, Klein was also studying single-cell transcriptomes, applying mathematical approaches to understand cell fate in tissue development and regeneration.

The prize of $50,000, to be divided between Regev and Klein, will be presented in a virtual ceremony at the 158th annual meeting of the National Academy of Sciences. It is named for its donor, businessman Bob James, the former chairman and CEO of the advertising agency McCann Erickson Worldwide.

ASBMB Today Staff
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in People

People highlights or most popular articles

Spriggs to start lab; Cejka joins EMBO
Member News

Spriggs to start lab; Cejka joins EMBO

Aug. 2, 2021

Awards, promotions, milestones and more. Find out what's going on in the lives of ASBMB members.

In memoriam: Gerhard Meissner
In Memoriam

In memoriam: Gerhard Meissner

Aug. 2, 2021

He was a professor at the University of North Carolina at Chapel Hill and an ASBMB member for more than 40 years.

Meet Stephanie Moon
Observance

Meet Stephanie Moon

Aug. 2, 2021

She studies messenger RNA regulation at the University of Michigan in Ann Arbor.

Journal of Biological Chemistry names new editor-in-chief
Journal News

Journal of Biological Chemistry names new editor-in-chief

July 30, 2021

Alex Toker, professor of pathology at the Beth Israel Deaconess Medical Center and Harvard Medical School, will begin his term Oct. 1.

Conaway named vice provost; Emr wins Shaw Prize; remembering Hartley
Member News

Conaway named vice provost; Emr wins Shaw Prize; remembering Hartley

July 26, 2021

Awards, promotions, milestones and more. Find out what's going on in the lives of ASBMB members.

Remembering Turk and Yamamoto
In Memoriam

Remembering Turk and Yamamoto

July 19, 2021

We look back on the lives of a mass spectrometry pioneer and member of the JBC editorial board and a researcher focused on enzymology and the biochemistry of lipids involved in inflammation.